NeuroPace (NPCE) announced the appointment of Scott Huennekens to its board of directors, effective January 6. Huennekens currently serves as chair of the board of directors of Envista Holdings (NVST) and chair of the board of directors of Hyperfine (HYPR).
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on NPCE:
- NeuroPace reports sees Q4 revenue $21M-$21.5M, consensus $20.91M
- NeuroPace narrows FY24 revenue view to $79.4M-$79.9M from $78M-$80M
- NeuroPace price target raised to $14 from $9 at JPMorgan
- NeuroPace completes enrollment in RNS System IDE study
- NeuroPace price target lowered to $13 from $15 at Wells Fargo
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
